A Retrospective Study of the Management of Vulvodynia
Jeon Yong-Seok, 김영준, Shim Bo-Sun, 윤하나, 박영요, 심봉석, 정우식, 이동현,
소속 상세정보
( Jeon Yong-Seok )
Ewha Womans University School of Medicine Department of Urology
김영준 ( Kim Young-Jun )
Ewha Womans University School of Medicine Department of Urology
( Shim Bo-Sun )
Ewha Womans University School of Medicine Department of Urology
윤하나 ( Yoon Ha-Na )
Ewha Womans University School of Medicine Department of Urology
박영요 ( Park Young-Yo )
Ewha Womans University School of Medicine Department of Urology
심봉석 ( Shim Bong-Suk )
Ewha Womans University School of Medicine Department of Urology
정우식 ( Jeong Woo-Sik )
Ewha Womans University School of Medicine Department of Urology
이동현 ( Lee Dong-Hyun )
Ewha Womans University School of Medicine Department of Urology
KMID : 0358320130540010048
Abstract
Purpose: Vulvodynia is characterized by chronic vulvar pain caused by sexual intercourse and often results in female sexual dysfunction. Because the causes of vulvodynia are not clear, many patients do not receive optimal treatment. Recently, gabapentin and botulinum toxin A have both been shown to be effective treatments for vulvodynia. In this study, we retrospectively analyzed the clinical outcomes of botulinum toxin A and gabapentin treatment for chronic pain in women with this condition.
Materials and Methods: Seventy-three women with vulvar pain were administered either gabapentin (n=62) or botulinum toxin A (n=11) injections. Effectiveness was measured by use of a visual analogue scale (VAS). We analyzed the treatment method, treatment duration, success of treatment, and side effects or adverse reactions.
Results: Pain levels in both groups significantly decreased after treatment. In the gabapentin group, the VAS score decreased from 8.6 before treatment to 3.2 after treatment (p<0.001). The VAS score in the botulinum toxin A group was reduced from 8.1 to 2.5 (p<0.001). Side effects for both therapies were few and subsided with treatment with general antibiotics and nonsteroidal antiinflammatory drugs.
Conclusions: Gabapentin and botulinum toxin A are safe and effective treatments for vulvodynia. This condition can cause sexual dysfunction and affect quality of life. However, with proper management, satisfactory outcomes for women with vulvodynia can be achieved.
키워드
Dyspareunia; Gabapentin;Type A botulinum toxins;Vulvodynia
원문 및 링크아웃 정보
등재저널 정보